‘This Is Not Good For Business’: Trump’s Workforce Shakeups Could Harm Industry

 
• By Sarah Karlin-Smith

Experts worry new restrictions on remote work, plans to eliminate certain employees’ job protections and workforce cuts will make the FDA a less attractive employer and hurt pharma’s efforts to get innovative medicines to patients.

office items flying around a room
Chaos and uncertainty for the federal workforce could negatively impact pharma. (Shutterstock)

More from US FDA

More from Pathways & Standards